Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation
Authors
Keywords
-
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2019-11-11
DOI
10.1161/circoutcomes.119.006212
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparative stroke, bleeding, and mortality risks in older Medicare patients treated with oral anticoagulants for nonvalvular atrial fibrillation
- (2019) David J. Graham et al. AMERICAN JOURNAL OF MEDICINE
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2019) Craig T. January et al. CIRCULATION
- Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation
- (2018) Tze-Fan Chao et al. CIRCULATION
- Net clinical benefit of anticoagulant treatments in elderly patients with nonvalvular atrial fibrillation: Experience from the real world
- (2018) Hilmi Alnsasra et al. HEART RHYTHM
- Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial FibrillationClinical Perspective
- (2016) Jonas Oldgren et al. CIRCULATION
- The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation
- (2016) Ziad Hijazi et al. EUROPEAN HEART JOURNAL
- Comparison of the ATRIA, CHADS 2 , and CHA 2 DS 2 -VASc stroke risk scores in predicting ischaemic stroke in a large Swedish cohort of patients with atrial fibrillation
- (2016) Sara Aspberg et al. EUROPEAN HEART JOURNAL
- Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study
- (2016) Jeffrey M. Ashburner et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Developing an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making
- (2015) Mark H. Eckman et al. CURRENT MEDICAL RESEARCH AND OPINION
- Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation
- (2015) Hendrika A. van den Ham et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Excess Mortality among Persons with Type 2 Diabetes
- (2015) Mauro Tancredi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Integrating Real-Time Clinical Information to Provide Estimates of Net Clinical Benefit of Antithrombotic Therapy for Patients With Atrial Fibrillation
- (2014) Mark H. Eckman et al.
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2014) Craig T. January et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cost-Effectiveness of CT Screening in the National Lung Screening Trial
- (2014) William C. Black et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Net Clinical Benefit of Warfarin Anticoagulation in Atrial Fibrillation
- (2013) Daniel E. Singer ANNALS OF INTERNAL MEDICINE
- Net Clinical Benefit of Adding Clopidogrel to Aspirin Therapy in Patients With Atrial Fibrillation for Whom Vitamin K Antagonists Are Unsuitable
- (2013) Stuart J. Connolly ANNALS OF INTERNAL MEDICINE
- Epidemiology of Heart Failure
- (2013) Véronique L. Roger CIRCULATION RESEARCH
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- A New Risk Scheme to Predict Ischemic Stroke and Other Thromboembolism in Atrial Fibrillation: The ATRIA Study Stroke Risk Score
- (2013) Daniel E. Singer et al. Journal of the American Heart Association
- Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation
- (2012) Leif Friberg et al. CIRCULATION
- Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study
- (2012) Leif Friberg et al. EUROPEAN HEART JOURNAL
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a ‘real world’ atrial fibrillation population: A modelling analysis based on a nationwide cohort study
- (2011) Amitava Banerjee et al. THROMBOSIS AND HAEMOSTASIS
- A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
- (2010) Ron Pisters et al. CHEST
- Cost-Effectiveness of Aspirin Use Among Persons With Newly Diagnosed Type 2 Diabetes
- (2010) R. Li et al. DIABETES CARE
- Competing Risk of Death: An Important Consideration in Studies of Older Adults
- (2010) Sarah D. Berry et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Identifying Patients at High Risk for Stroke Despite Anticoagulation
- (2010) Gregory Y.H. Lip et al. STROKE
- Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
- (2009) Gregory Y.H. Lip et al. CHEST
- Heart Disease and Stroke Statistics—2010 Update
- (2009) et al. CIRCULATION
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation